Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 45,601 | 0.1% | 59,079 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 34,908 | 0.1% | 62,084 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 29,931 | 0.1% | 57,012 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 42,281 | 0.1% | 66,665 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 42,664 | 0.1% | 59,893 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 67,464 | 0.2% | 64,176 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 60,365 | 0.2% | 57,434 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 55,231 | 0.1% | 57,383 | 3/31/2024 |
| 2023 Q4 | 2/12/2024 | 48,906 | 0.1% | 55,683 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 47,244 | 0.1% | 57,407 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 47,672 | 0.1% | 66,346 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 54,580 | 0.2% | 66,426 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 49,021 | 0.2% | 67,944 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 48,701 | 0.2% | 70,697 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 51,023 | 0.1% | 86,314 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 64,113 | 0.1% | 91,797 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 42,166 | 0.1% | 66,769 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 43,750 | 0.1% | 72,292 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 36,658 | 0.1% | 65,631 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 35,178 | 0.1% | 74,350 | 3/31/2021 |
| 2020 Q4 | 2/3/2021 | 41,158 | 0.1% | 85,193 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 47,964 | 0.1% | 85,683 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 73,057 | 0.2% | 117,144 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 22,193 | 0.1% | 45,450 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 22,824 | 0.1% | 60,786 | 12/31/2019 |
| 2014 Q1 | 5/14/2014 | 17,191 | 0.1% | 57,250 | 3/31/2014 |
| 2013 Q4 | 2/12/2014 | 15,746 | 0.1% | 57,210 | 12/31/2013 |